Page last updated: 2024-10-31

neostigmine and Digestive System Diseases

neostigmine has been researched along with Digestive System Diseases in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Digestive System Diseases: Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murney, RG1
Winship, DH1

Reviews

1 review available for neostigmine and Digestive System Diseases

ArticleYear
The irritable colon syndrome.
    Clinics in gastroenterology, 1982, Volume: 11, Issue:3

    Topics: Animals; Cats; Cholecystokinin; Colon; Colonic Diseases, Functional; Dietary Fiber; Digestive System

1982